Cargando…
Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
Vaccination against the SARS-CoV-2 virus or infection with SARS-CoV-2 will lead to the development of IgG antibodies against the S1 protein of the SARS-CoV-2 virus. However, even despite having high levels of IgG antibodies against the S1 protein of the SARS-CoV-2 virus, (re-)infection may occur. We...
Autores principales: | Hocher, Berthold, Schönbrunn, Anne, Chen, Xin, Krämer, Bernhard K., von Baehr, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611994/ https://www.ncbi.nlm.nih.gov/pubmed/36296343 http://dx.doi.org/10.3390/microorganisms10102067 |
Ejemplares similares
-
Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
por: Chu, Chang, et al.
Publicado: (2022) -
T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells
por: Chu, Chang, et al.
Publicado: (2022) -
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
por: Wan, Jinkai, et al.
Publicado: (2020) -
Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022) -
Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)